Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma (NCT02086175) | Dana-Farber Cancer Institute | 2014-12-01 |
Track Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas automatically
Every clearance here is in the API, with alerts when new ones post.